Yrglm Obtains Patent for AI Tech Estimating Planning Intent from Ads and LPs
Key facts
- Yrglm Obtains Patent for AI Tech Estimating Planning Intent from Ads and LPs
- Yrglm Inc. secured Patent No. 7853683 on April 21, 2026, for AI that analyzes ads and LPs to automatically estimate marketing campaign planning intent and hypotheses to store as organizational assets.
- Source: PR Times
- Date: June 5, 2026
Direct answer
Yrglm Inc. secured Patent No. 7853683 on April 21, 2026, for AI that analyzes ads and LPs to automatically estimate marketing campaign planning intent and hypotheses to store as organizational assets.
- Citation
- Yrglm Obtains Patent for AI Tech Estimating Planning Intent from Ads and LPs (June 5, 2026), PR Times
- Source
- PR Times
- Date
- June 5, 2026
Yrglm Inc. secured Patent No. 7853683 on April 21, 2026, for AI that analyzes ads and LPs to automatically estimate marketing campaign planning intent and hypotheses to store as organizational assets.
📋 Article Processing Timeline
- 📰 Published: June 5, 2026 at 11:00
- 🔍 Collected: June 5, 2026 at 11:26 (26 min after Published)
- 🤖 AI Analyzed: June 6, 2026 at 18:08 (30h 42m after Collected)
FAQ
What is the patent number and registration date of the newly acquired patent?
The patent number is No. 7853683, and it was registered on April 21, 2026.
Which service features this patented technology?
It is integrated as the core technology for the 'AI Planning Estimation' feature of the marketing campaign management platform 'AD EBiS Campaign Manager'.
What specific 'planning intents' does the AI automatically estimate using this technology?
It analyzes advertisement creative assets and landing page URLs to estimate the promoted product, target audience, and the planning intent or hypothesis.
Who are the patent holder and the inventor?
The patent holder is YRGLM Inc., and the inventor is Susumu Iwata (Representative Director) and others.
What are the establishment date and headquarters locations of YRGLM Inc.?
It was established on June 4, 2001. The Osaka Headquarters is at 8F Herbis ENT Office Tower, 2-2-22 Umeda, Kita-ku, Osaka, and the Tokyo Headquarters is at 12F X-PRESS Yurakucho, 2-2-1 Yurakucho, Chiyoda-ku, Tokyo.